Study of Poly (ADP-Ribose) Polymerase (PARP) Inhibitor E7016 in Combination With Temozolomide in Subjects With Advanced Solid Tumors
Clinical trial NCT01127178 · TERMINATED
Trial details
- NCT number
- NCT01127178
- Sponsor
- Eisai Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-29
- Primary completion
- 2011-02-24
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.